drugset / Trial / NCT01148147

Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary Angioplasty

NCT01148147

RandomizedSingle-groupQuadruple-blindPrevention

Summary

Aim of the study is to evaluate the benefits from adjunctive intracoronary administration of adenosin in elective patients undergoing coronary angioplasty.

Timeline

Start
2009-11
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adenosine Small molecule 120 ug Other
Comparator Adenosine Small molecule 180 ug Other